PT  - JOURNAL ARTICLE
AU  - Saarang Singh
AU  - Ankur A. Patel
AU  - Jaspal R. Singh
TI  - Intervertebral Disc Degeneration: The Role and Evidence for Non–Stem-Cell-Based Regenerative Therapies
AID  - 10.14444/8055
DP  - 2021 Apr 01
TA  - International Journal of Spine Surgery
PG  - 54--67
VI  - 15
IP  - s1
4099  - http://ijssurgery.com//content/15/s1/54.short
4100  - http://ijssurgery.com//content/15/s1/54.full
SO  - Int J Spine Surg2021 Apr 01; 15
AB  - The use of non–stem-cell-based regenerative medicine therapies for lumbar discogenic pain is an area of growing interest. Although the intervertebral disc is a largely avascular structure, cells located within the nucleus pulposus as well as annulus fibrosis could be targeted for regenerative and restorative treatments. Degenerative disc disease is caused by an imbalance of catabolic and anabolic events within the nucleus pulposus. As catabolic processes overwhelm the environment within the nucleus pulposus, proinflammatory cytokines increase in concentration and lead to further disc degeneration. Non–stem-cell-based therapies, which include growth factor therapy and other proteins, can lead to an increased production of collagen and proteoglycans within the disc.